Growth Metrics

CorMedix (CRMD) Non-Current Assets (2016 - 2025)

CorMedix (CRMD) has disclosed Non-Current Assets for 13 consecutive years, with $459.1 million as the latest value for Q4 2025.

  • Quarterly Non-Current Assets rose 10649.03% to $459.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $959.7 million through Dec 2025, up 5275.36% year-over-year, with the annual reading at $459.1 million for FY2025, 10649.03% up from the prior year.
  • Non-Current Assets hit $459.1 million in Q4 2025 for CorMedix, down from $491.3 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $491.3 million in Q3 2025 to a low of $1.2 million in Q2 2021.
  • Historically, Non-Current Assets has averaged $52.7 million across 5 years, with a median of $2.5 million in 2021.
  • Biggest five-year swings in Non-Current Assets: fell 1.9% in 2023 and later soared 10986.07% in 2025.
  • Year by year, Non-Current Assets stood at $2.5 million in 2021, then rose by 0.42% to $2.5 million in 2022, then dropped by 4.84% to $2.4 million in 2023, then surged by 80.46% to $4.3 million in 2024, then skyrocketed by 10649.03% to $459.1 million in 2025.
  • Business Quant data shows Non-Current Assets for CRMD at $459.1 million in Q4 2025, $491.3 million in Q3 2025, and $4.5 million in Q2 2025.